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Abstract
Background: Recent studies suggest that surrogate decision makers may be too optimistic about their end-of-life
decision making abilities for loved ones. We examined surrogates’ decision making confidence with an emphasis
on its linkages to their understandings of patients’ values and goals for end-of-life care.
Methods: We used baseline data from a randomized trial with 58 dyads of African-American dialysis patients
and their surrogates who separately completed the Values of Life-Sustaining Treatment Outcomes and the Goals
of Care documents. Surrogates also completed a Surrogate Decision Making Confidence Scale.
Results: Overall, 60% of surrogates were unsure how their loved ones would feel about continuing life-
sustaining treatment, including dialysis, in at least one of the four outcomes presented in the Values of Life-
Sustaining Treatment Outcomes. For goals of care near end of life, 67.2% to 69.0% of patients preferred comfort
care only, but only 20 (34.5%) surrogates were congruent with patients on Goals of Care. Nonetheless, surro-
gates’ confidence was high (M = 3.23 out of 4.0). Surrogates’ confidence was positively associated with dyad
congruence in values for life-sustaining treatment at only a small magnitude (Spearman’s rho = .31, p = .02), but
not with dyad congruence in goals of care (v2 = 2.13, df = 1, p = .19).
Conclusions: Surrogates’ confidence had little association with their actual understanding of patients’ values and
goals. Interventions to prepare patients and surrogates for end-of-life decision making may need to address
overconfidence and help surrogates recognize their limited understanding of patients’ values and goals.
Introduction
The number of patients in the United States with end-stage kidney disease (ESKD) who require dialysis is in-
creasing rapidly with the aging of the population and the
epidemic of diabetes mellitus.1 Mortality in this population is
high; over 80,000 patients with ESKD die every year primarily
due to acute illnesses (e.g., infection and cardiovascular dis-
ease) associated with comorbidities.1 In the absence of patient
competence to make decisions as to whether to continue or
stop dialysis near end of life, family members or surrogate
decision makers are asked to make those difficult decisions.2
This issue has been particularly challenging in the care of
African Americans because they are thought to prefer ag-
gressive treatment at the end of life and to be reluctant to stop
life-sustaining treatment when its benefits are in doubt.3–7
Few African Americans make their wishes known to their
surrogates, and discussions often remain too vague to guide
surrogate decision makers.8, 9 Studies have shown that,
without an effective communication intervention to improve
surrogates’ understanding of patients’ wishes, surrogates’
judgments are only modestly correlated with patients’ pref-
erences.10–14 Further, surrogates’ judgments are more highly
related to their own preferences than to dialysis patient’s
preferences.15
While the extent to which surrogate decision making is
based on patients’ actual preferences is uncertain at best, re-
cent studies have suggested that surrogates may be too con-
fident (too optimistic) about their ability to represent their
loved one’s wishes in end-of-life decisions.16–18 Under-
standing the relationship between surrogate confidence and
their understanding of patients’ wishes has clinical and re-
search implications for how to better assist patients and their
surrogates in end-of-life decision making. If both patients and
their surrogates falsely believe that the surrogates have a good
understanding of patients’ wishes and that their surrogates
would be able to make end-of-life decisions, such confidence
may preclude them from engaging in end-of-life discussions.
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The purpose of this paper was to examine surrogate deci-
sion making confidence, with an emphasis on its linkages to
their understandings of patients’ values and goals for end-of-
life care. Data from 58 dyads of African-American dialysis
patients and their surrogate decision makers were used. To
address decision making confidence, we first determine if our
data replicate previous work demonstrating lack of congru-
ence between patients and surrogates on values and goals.
The specific research questions were as follows. For African
Americans with ESKD,
1. What values for life-sustaining treatment, based on
likely outcomes, are held?
2. Is there congruence in values for life-sustaining treat-
ment within the dyad? In other words, are surrogates’
predictions of their loved ones’ values congruent with
patients’ values?
3. What goals of care at the end of life are preferred?
4. Is there congruence in goals of care at the end of life
within the dyad? In other words, are surrogates’ pre-
dictions of their loved ones’ preferences for goals of
care congruent with patients’ choices?
5. What is the level of decision making confidence in the
surrogates?
6. Is there an association between surrogate decision
making confidence and (a) dyad congruence in values
for life-sustaining treatment and (b) dyad congruence
in goals of care?
Methods
Design and sample
We used baseline data collected during a randomized
controlled trial in which an end-of-life communication inter-
vention was tested with 58 dyads of African-American
dialysis patients and their surrogate decision makers.18
The original study, conducted from 2006 to 2009, included
three measurement time points (baseline, one week post-
intervention, and three months).
Patients were deemed eligible for the original study if they
met the following criteria: self-identified African American,
receiving dialysis for at least three months before enrollment,
availability of a surrogate chosen by the patient who could be
present during the intervention, over age 18, and able to speak
English. Social workers at the dialysis clinics approached 125
potential patient participants from six outpatient dialysis
clinics in western Pennsylvania to assess their eligibility.
Subsequently, the research staff approached patients who
indicated an interest in the study for informed consent and a
cognitive function test, the 10-item Short Portable Mental
Status Questionnaire (SPMSQ).19 Patients with > 2 errors on
the SPMSQ were deemed ineligible. Upon patients’ consent,
the research staff contacted their surrogates and invited them
to join the study if they were over age 18, able to speak En-
glish, and willing to participate in the intervention with the
patients. Of the 118 eligible patients, 87 (73.7%) consented; of
those, 58 of the chosen surrogates (66.6%) agreed to partici-
pate. See Table 1 for patient and surrogate characteristics.
Tools and data collection
Study procedures were approved by the institutional re-
view board of the primary institution of the project. At base-
line, each member of the dyad separately completed
questionnaires at the dialysis clinic.
Values of life-sustaining treatment outcomes.20 This
tool assessed the patient’s threshold for unacceptable out-
comes of life-sustaining treatment. This tool asked patients to
imagine that they developed cancer that has spread or that
they have had a severe stroke or heart attack and became
seriously ill at the hospital. Patients then were asked to think
about conditions that for them would be worse than death
and they would want their family member to make a decision
to stop life-sustaining treatment, including dialysis, and focus
on treatment to make them as comfortable as possible. Patients
were presented with four outcomes and asked whether the
outcome would be ‘‘acceptable,’’ ‘‘unacceptable,’’ or ‘‘unsure.’’
The four outcomes of life-sustaining treatment were: cannot
recognize my family or friends, only respond to pain and yet in un-
treatable pain most of the time, can no longer control my bowels, and
have to live in a nursing home until death. One-week test-retest
reliability in 29 patients (assessed using probability of agree-
ment with 95% confidence interval for each outcome) ranged
0.70 to 0.72 (95% CI = 0.50 to 0.86) in a previous study.20
Table 1. Sample Characteristics
n (%)
Patient
Age, M – SD 57.93 – 11.9
Male 33 (56.9)
Married or living with partner 22 (37.9)
Completed high school 50 (86.2)
Protestant, Religious affiliation 43 (74.1)
Religious involvement
Frequently or always 36 (62.1)
Importance of spirituality in life
Extremely important 36 (62.1)
Annual household income
< $13,000 24 (41.4)
$13,000 - $29,000 17 (29.3)
> $29,000 17 (29.3)
Medicare, Insurance 46 (79.3)
Time on dialysis in year, median 4.13
Charlson Comorbidity Index, M – SD 6.35 – 2.1
Surrogate
Age, M – SD 49.52 – 12.7
Male 14 (24.1)
White 3 (5.2)
Completed high school 50 (86.2)
Relationship to patient




Other relative or frienda 11 (19.0)
Protestant, Religious affiliation 42 (72.4)
Religious involvement
Frequently or always 41 (70.7)
Importance of spirituality in life
Extremely important 46 (79.3)
aIncluding ex-wives, in-laws, grandchildren, and nieces.
M, mean; SD, standard deviation.
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The surrogate version asked respondents whether the out-
come would be acceptable or not acceptable to their loved ones
or if they were unsure. For each of the four values, congruence
was determined by whether the patient and surrogate both
responded ‘‘acceptable’’ or both responded ‘‘unacceptable.’’ If
both members of the dyad responded ‘‘unsure,’’ this was not
considered congruent. In our analyses we report the percentage
of dyads that were congruent on each value, the congruence
score (a sum of the values [0 to 4] on which dyads were con-
gruent), and the number of values on which surrogates were
unsure of their loved one’s values.
Goals of care document.17,18 This document assessed
patients’ end-of-life treatment preferences using two scenar-
ios describing medical conditions that commonly occur in
patients with ESKD. The first scenario described a condition
in which the patient develops cancer that spreads or has se-
vere complications and cannot speak for himself/herself. The
medical team believes that recovery is unlikely and that
continuing life-sustaining treatment, including dialysis, is no
longer beneficial. The second scenario described a condition
in which the patient develops advanced dementia and he or
she can no longer be him/herself. His/her dementia is no
longer responding to treatment. For each scenario, patients
were asked to choose one of three options: ‘‘the goals of care
should be focused on delaying my death, and thus I want to
continue life-sustaining treatment;’’ ‘‘the goals of care should
be focused on my comfort and peace, and thus I do not want
life-sustaining treatment, including dialysis;’’ and ‘‘I am not
sure.’’ One-week test-retest reliability in 29 patients (the
probability of agreement with 95% confidence interval) ran-
ged 0.76 to 0.86 (95% CI = 0.60 to 0.92) in a previous study.20
The surrogate version asked respondents to choose one of
the two options that indicates best what their loved one’s
preference would be for each scenario or the option, ‘‘I am not
sure,’’ if they were uncertain about their loved ones’ preference.
To determine congruence on goals of care, patients’ and sur-
rogates’ responses were first stratified into delaying death in
both scenarios, mixed (delaying death in one scenario and comfort
care only in the other scenario), and comfort care only in both
scenarios. Dyads were categorized as being congruent or in-
congruent as follows. A dyad was considered congruent if both
the patient’s and surrogate’s responses were stratified into one
of the three categories delaying death, mixed, and comfort care
only. In the case when both members of the dyad chose ‘‘I am
not sure,’’ the dyad was not considered congruent.
Decision making confidence scale.17,18 This scale
measured surrogates’ confidence in end-of-life decision
making for their loved ones. It consists of five items with
response options from 0 (Not Confident At All) to 4 (Very
Confident), reflecting level of comfort in the surrogate role
(Cronbach’s a = 0.85). For example, one item was ‘‘I feel con-
fident that I understand what my loved one’s preferences
are.’’ A total score is a mean of the five items.
Other descriptive data included sociodemographic infor-
mation, such as age, gender, education, annual household
income, health insurance status, the importance of religion or
spirituality in life on a four-point scale from 1 (Not At All
Important) to 4 (Extremely Important), and the extent of fol-
lowing religious customs on a four-point scale from 1 (Not At
All) to 4 (Always). From medical record reviews we deter-
mined the duration of dialysis and the Charlson Comorbidity
Index (CCI).21 The CCI includes 19 comorbid conditions, in-
cluding myocardial infarction, congestive heart failure, AIDS,
cerebrovascular disease, and liver disease. A higher score in-
dicates a greater risk of mortality.21–23
Data analysis
Descriptive statistics (mean, SD, frequency, percent) were
used to summarize sample characteristics, patients’ values for
life-sustaining treatment, dyad congruence on values, pa-
tients’ goals of care, dyad congruence on goals of care, and
surrogate decision making confidence. To examine the rela-
tionship of surrogate confidence to dyad congruence in values
for life-sustaining treatment, a Spearman’s rho was used. To
examine the relationship between surrogate decision making
confidence and dyad congruence in goals of care, a Fisher
exact test was employed. The relationship between number of
life-sustaining treatment outcomes on which the surrogate
was unsure and surrogate confidence was determined using a
Spearman’s rho.
Results
Patients’ values for life-sustaining treatment
and dyad congruence
Figure 1 presents patients’ values and surrogates’ predic-
tion of their loved ones’ values for life-sustaining treatment.
The outcome endorsed as unacceptable by the highest per-
centage of patients (81%) was a condition with the loss of
bowel control, necessitating dependence on others for basic
needs. Forty-one patients (70.7%) said that the outcome of
untreatable pain would be unacceptable to them and they
would want their family member to make a decision to stop
all life-sustaining treatment, including dialysis. Nonetheless,
a sizable number of patients were unsure about their own
values, especially for the outcomes in which patients cannot
recognize their family or friends (25.9%) or have to live in a
nursing home until death (27.6%). Overall, 60% of surrogates
were unsure how their loved ones would feel about con-
tinuing or stopping life-sustaining treatment, including dial-
ysis, in at least one of the four outcomes.
Dyad congruence on values is presented in Table 2. The
outcome on which the largest number of dyads showed lack
of congruence was the condition in which the patient cannot
recognize his or her family or friends (69%). In other words,
nearly 70% of surrogates predicted their loved ones’ values for
this outcome inconsistently with the patients’ values or were
unsure of the patients’ values. Conversely, the outcome on
which the largest number of dyads were congruent was only
respond to pain.wherein 27 (46.6%) of the dyads were con-
gruent. Overall, out of the four possible outcomes, the mean
number of outcomes of life-sustaining treatment on which
dyads showed congruence was 1.60 (SD = 1.39).
Patients’ preferences for goals of care
and dyad congruence
For goals of care near end of life, the majority of patients
(67.2% in scenario 1 and 69.0% in scenario 2) said that
they would want the focus to be on comfort care only and
that life-sustaining treatment, including dialysis, should be
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withdrawn (Figure 2). For scenario 1, a large percentage of
surrogates (63.8%) also selected focusing on comfort, but in
scenario 2 only 46.6% of surrogates selected focusing on
comfort. In addition, while quite a few patients were unsure of
their own wishes (13.8% in scenario 1 and 17.2% in scenario 2),
fully 31% of surrogates were unsure about what goals of care
their loved ones would prefer in the condition of advanced
dementia that is no longer responsive to treatment. Finally, in
categorizing dyads as either congruent or not, only 20 (34.5%)
dyads were congruent on both scenarios.
Surrogates’ decision making confidence
and its association with dyad values
and goals congruence
Table 3 presents data regarding surrogates’ decision mak-
ing confidence. In general, decision making confidence was
high (M = 3.23), as were scores on each of the items in the scale.
Another way to consider the data is that 46 surrogates (79.3%)
scored between 3 (Confident) and 4 (Very Confident). Only
one surrogate characteristic, i.e., the extent of following reli-
gious customs, was correlated (inversely) with decision
making confidence (Spearman’s rho = - 0.30, n = 58, p = 0.03).
Surrogate confidence was positively associated with dyad
congruence in values for life-sustaining treatment, but the
magnitude of the correlation was small (Spearman’s rho =
0.31, n = 58, p = 0.02). Alternatively, surrogate confidence was
not associated with dyad congruence in goals of care
(v2 = 2.13, df = 1, p = 0.19; Table 4); in short, regardless of
whether the surrogates’ responses in the Goals of Care doc-
ument were congruent with the patients’ goals or not, surro-
gates felt confident in end-of-life decision making on behalf of
their loved ones.
To further explore surrogates’ overconfidence in under-
standing patients’ values, we examined the association be-
tween surrogate decision making confidence and the number
of values for life-sustaining treatment on which they were
unsure about their loved one’s values. An inverse association
(Spearman’s rho = - 0.51, n = 58, p < 0.001) was found. In other
words, the more outcomes on which a surrogate was able
to respond either ‘‘acceptable’’ or ‘‘unacceptable’’ to their
loved ones – whether their answers were actually congruent
with the patient’s wishes or not – the more confident was the
surrogate.
Discussion
Decisions to stop life-sustaining treatment, particularly
dialysis, are extremely difficult to think about for patients
whose lives have been dependent on dialysis.24,25 Under-
standably, discussions about end-of-life care are often avoi-
ded, and this may leave both patients and their family
members and surrogates unprepared for those decisions.26,27
Although previous studies have demonstrated that congru-
ence between patients and surrogates in end-of-life treatment
preferences is low,10–13 our findings offer additional useful
information to improve approaches to end-of-life communi-
cation.
For example, patients themselves may be unsure about
their own values and care goals at the end of life. Therefore,
they need opportunities to explore their own values in order
to be able to provide instructions to their surrogates. We also
found that end-of-life preferences in our sample differed from
previous literature describing African Americans as prefer-
ring not to stop life-sustaining treatment.3–7 In this sample, a
substantial number of African-American dialysis patients
preferred comfort care over life-sustaining treatment, in-
cluding dialysis. Although the patients expressed their pref-
erences in response to hypothetical situations, these data
challenge conventional beliefs about African Americans’ end-
of-life preferences. It is important for clinicians and re-
searchers to be aware that there are diverse perspectives
Table 2. Number (%) of Dyads Congruent in Values
for Life-Sustaining Treatment Outcomes
Congruent Incongruent
n (%) n (%)
Cannot recognize family or friends 18 (31.0) 40 (69.0)
Only respond to pain and yet
in untreatable pain most
of the time
27 (46.6) 31 (53.4)
Can no longer control bowels 24 (41.4) 34 (58.6)
Have to live in a nursing home
until death
24 (41.4) 34 (58.6)
FIG. 1. Number (%) of patient preferences
and surrogate predictions of values for life-
sustaining treatment outcomes.
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among African Americans about continuing life-sustaining
treatment when the outcome is considered unacceptable.20
In our sample, surrogates tended to choose a response that
reflects a focus on delaying death. Given the low congruence
in both values for life-sustaining treatment and goals of care,
these responses are likely to reflect their own values or diffi-
culty choosing otherwise (and thus selecting a less distressing
option).28 We also confirmed the results of previous stud-
ies16–18 that surrogates generally rated their decision making
confidence high. Yet their confidence had little to no asso-
ciation with dyad congruence. This finding suggests that
surrogates may be too optimistic about their ability to make
end-of-life decisions for their loved ones because they may
not have realized their lack of knowledge of patients’ pref-
erences, what roles a surrogate decision maker would need
to play, and the burden associated with those roles. Much
greater attention must be given to surrogates as opposed to
focusing primarily on clarification and documentation of
patients’ wishes. To be effective, an intervention to prepare
patients and their surrogates for end-of-life decision making
will need to include components to provide patients enough
opportunity to explore their own values and to help surro-
gates recognize the extent of their understanding of patients’
values and potential difference between their own values
and patients’.
This study has several limitations. Although the sample
size of the original study was determined by the power nee-
ded to test an intervention, it still represents a small number of
African-American dyads. Also, the sample was recruited from
an urban area and vicinities and thus does not represent Af-
rican Americans residing in a rural area where perspectives
might be different. These limitations suggest the urgent need
for further study examining what has become the conven-
tional wisdom about African Americans’ preferences for life-
sustaining treatment as opposed to palliative care. That is,
could it be the peculiarities of our sample that resulted in
findings that differ from previous research, or is there in fact
greater diversity in African-American preferences than is
typically thought?
In summary, we found that congruence between African-
American dialysis patients and their surrogates in end-of-life
treatment preferences was low, but partly because some pa-
tients themselves were unsure about their own values and
preferences. We also found that a substantial number of Af-
rican Americans prefer comfort care over life-sustaining
treatment, including dialysis. Surrogates were generally
confident about their ability to make end-of-life decisions for
their loved ones without fully recognizing their lack of un-
derstanding of patients’ wishes. Our findings may be useful
FIG. 2. Number (%) of patients’ preferences
and surrogates’ predictions of goals of care
near end of life.
Table 3. Mean (SD) Surrogate Decision-Making
Confidence by Item and for Total Score
Item M – SD
I feel confident that .
1. I understand what my loved one’s
preferences are
2.93 – 1.31
2. I can make a decision for my loved
one as to what treatment he/she
should have, even
in a highly stressful situation
3.12 – 1.09
3. I can ask questions to get the facts
about the benefits or risks of each
medical choice without feeling
discouraged
3.47 – 0.88
4. I can handle unwanted pressure
from others, such as other family
members or health care providers,
in making decisions for my loved one
3.26 – 0.91
5. I can communicate with doctors
and nurses about my loved
one’s wishes
3.38 – 0.95
Total score 3.23 – 0.82
Table 4. Number (%) of Surrogates Who
Were Confident or Not Confident





n (%) n (%)
Surrogate scored 0–2
(Not Confident)
2 (3.4) 10 (17.2)
Surrogate scored 3–4
(Confident)
18 (31.0) 28 (48.3)
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for clinicians and researchers in helping dialysis patients and
their surrogates to prepare for end-of-life decision making.
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